Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
National Institutes of Health · National Cancer Institute
Abstract
Suppression of the host's immune system plays a major role in cancer progression. Tumor signaling of programmed death 1 (PD1) on T cells and expansion of myeloid-derived suppressor cells (MDSCs) are major mechanisms of tumor immune escape. We sought to target these pathways in rhabdomyosarcoma (RMS), the most common soft tissue sarcoma of childhood. Murine RMS showed high surface expression of PD-L1, and anti-PD1 prevented tumor growth if initiated early after tumor inoculation; however, delayed anti-PD1 had limited benefit. RMS induced robust expansion of CXCR2(+)CD11b(+)Ly6G(hi) MDSCs, and CXCR2 deficiency prevented CD11b(+)Ly6G(hi) MDSC trafficking to the tumor. When tumor trafficking of MDSCs was inhibited…
Citation impact
- FWCI
- 17.79
- Percentile
- 100%
- References
- 50
Authors
8- SLSteven L. Highfill
National Institutes of Health, National Cancer Institute
- YCYongzhi Cui
National Institutes of Health, National Cancer Institute
- AGAmber Giles
National Institutes of Health, National Cancer Institute
- JSJillian Smith
National Institutes of Health, National Cancer Institute
- HZHua Zhang
National Institutes of Health, National Cancer Institute
Topics & keywords
- CXC chemokine receptors
- Cancer research
- Medicine
- Immune system
- Immunology
- Immunosuppression
- Immune checkpoint
- Population
- Gender equality